About NHG Group Research & Innovation (GRI)
National Healthcare Group
The National Healthcare Group (NHG) is a leader in public healthcare in Singapore recognized for delivering high value patient care. Our clinical services are provided through an integrated system of primary care polyclinics, acute care tertiary hospitals, community hospitals, national specialty centres, and community-based ambulatory care centres.
With more than 20,000 healthcare professionals in NHG, we are committed towards building healthier and resilient communities, and Adding Years of Healthy Life to the people we serve.
Learn more about the National Healthcare Group (NHG) here.
NHG Group Research & Innovation
At NHG, we believe that Research and Innovation are at the heart of advancing healthcare.
Established in 2004 in NHG, the NHG Group Research & Innovation (GRI) is dedicated to cultivating medical research and developing innovative medical technologies through collaborative partnerships with our academic partners and the MedTech industry.
GRI's mission is to enhance patient care and outcomes through cutting-edge research and collaboration.
Our work focuses on enabling high quality, ethical research that:
-
Safeguards Research Participants’ Safety, Well-Being, and Rights
-
Improves Clinical and Health outcomes
-
Enhances Medical Quality and Cost-Effectiveness
-
Pioneers new Treatments and Patient Care innovations
-
Aligns with Singapore’s National Biomedical Research Priorities
Our Offices
The NHG Group Research & Innovation (GRI) comprises of the following
Offices.
Centre for Medical Technologies & Innovations (CMTi)
The NHG Centre for Medical Technologies & Innovations (CMTi) plays an integral role in the innovation ecosystem to help facilitate the development of innovative MedTech solutions that can address unmet healthcare needs and contribute to improved patient and healthcare outcomes. This is achieved through a structured framework that includes funding, talent development, and partnerships with academic and industry leaders.
-
Learn more about CMTi here.
Clinician-Scientist Development Office (CSDO)
The NHG Clinician Scientist Development Office (CSDO) facilitates and supports research in NHG by providing holistic support to nurture and develop clinician scientists and innovators, clinical researchers and research administrators in NHG; cultivate research culture through a critical mass of talents; and groom the next generation of research leaders and mentors.
Collaborating with academic and research institutions, our efforts strengthen the national pool of clinician scientists and innovators who in turn bring scientific research from the bench to beside.
-
Learn more about CSDO here.
Office of Human Research Protection Programme (OHRPP)
The NHG Office of Human Research Protection Programme (OHRPP) ensures the ethical conduct of human research by overseeing ethics reviews, providing researcher education, and monitoring compliance with regulations. The OHRPP is dedicated to protecting the rights and safety of research participants, maintaining high standards through international accreditation. OHRPP also engages in public outreach to promote awareness and understanding of participant rights in research. This commitment supports the ethical and effective conduct of research within NHG.
-
Learn more about OHRPP here.
Research Administration Office (RAO)
The Research Administration Office (RAO) supports all offices and units under GRI as the key liaison for research finance matters. In addition, RAO renders other administrative and technology support, such as reporting cluster's notable research and innovation KPIs/achievements; facilitating Clinical Trial (CT) related functions with internal and external stakeholders; serving as Secretariat for strategic committees; and providing technology support to develop digital solutions to enhance productive and efficiency.
Translational Research Office (TRO)
The Translational Research Office (TRO), a part of the Group Research & Innovation (GRI) in the National Healthcare Group (NHG), facilitates and supports translational research initiatives and activities at NHG. TRO works closely with partners within and across the ecosystem, including the Lee Kong Chian School of Medicine, to establish joint institutes, programmes, and projects that leverage the clinical strengths of NHG and complementary capabilities of our partners. TRO also works with internal and external stakeholders to support the management of research agreements, internal/joint grants and funding, as well as intellectual property (IP) developed by NHG staff. These in turn enable and facilitate the generation of new knowledge and insights towards better prevention, diagnosis, treatment and management of diseases, as well as maintenance of health, in alignment with NHG’s vision and mission.